| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.0049 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |